"This cold weather and extreme snowstorm are not an exception to global warming, but an alarming indicator of it," the author ...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that Health Canada has authorized the tablet formulation of LIVMARLI ® (maralixibat) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results